Simplex Trading’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,100
| Closed | -$4K | – | 10048 |
|
|
2024
Q4 | $4K | Sell |
8,100
-13,100
| -62% | -$9.13K | ﹤0.01% | 7811 |
|
|
2024
Q3 | $37K | Sell |
21,200
-38,000
| -64% | -$53K | ﹤0.01% | 6174 |
|
|
2024
Q2 | $69K | Buy |
59,200
+20,800
| +54% | +$52K | ﹤0.01% | 5758 |
|
|
2024
Q1 | $347K | Sell |
38,400
-113,100
| -75% | -$1.1M | ﹤0.01% | 4233 |
|
|
2023
Q4 | $1.65M | Sell |
151,500
-133,600
| -47% | -$1M | ﹤0.01% | 2531 |
|
|
2023
Q3 | $2.29M | Buy |
285,100
+197,700
| +226% | +$1.64M | ﹤0.01% | 1957 |
|
|
2023
Q2 | $949K | Buy |
87,400
+64,600
| +283% | +$553K | ﹤0.01% | 2651 |
|
|
2023
Q1 | $157K | Sell |
22,800
-16,000
| -41% | -$100K | ﹤0.01% | 4611 |
|
|
2022
Q4 | $154K | Buy |
38,800
+22,300
| +135% | +$110K | ﹤0.01% | 4555 |
|
|
2022
Q3 | $109K | Buy |
16,500
+15,600
| +1,733% | +$96K | ﹤0.01% | 5407 |
|
|
2022
Q2 | $4K | Sell |
900
-50,800
| -98% | -$309K | ﹤0.01% | 9064 |
|
|
2022
Q1 | $483K | Buy |
51,700
+33,000
| +176% | +$328K | ﹤0.01% | 3889 |
|
|
2021
Q4 | $222K | Buy |
18,700
+700
| +4% | +$8.08K | ﹤0.01% | 5040 |
|
|
2021
Q3 | $336K | Hold |
18,000
| – | – | ﹤0.01% | 4720 |
|
|
2021
Q2 | $322K | Buy |
18,000
+17,685
| +5,614% | +$284K | ﹤0.01% | 4864 |
|
|
2021
Q1 | $487K | Buy |
+315
| New | +$4.56K | ﹤0.01% | 3419 |
|
|
2020
Q4 | – | Sell |
-533
| Closed | -$683K | – | 9257 |
|
|
2020
Q3 | $683K | Buy |
533
+443
| +492% | +$3.82K | ﹤0.01% | 2664 |
|
|
2020
Q2 | $91K | Buy |
90
+75
| +500% | +$690 | ﹤0.01% | 4886 |
|
|
2020
Q1 | $11K | Sell |
15
-106
| -88% | -$918 | ﹤0.01% | 6432 |
|
|
2019
Q4 | $104K | Buy |
121
+13
| +12% | +$73 | ﹤0.01% | 4485 |
|
|
2019
Q3 | $66K | Sell |
108
-156
| -59% | -$1.26K | ﹤0.01% | 4754 |
|
|
2019
Q2 | $437K | Buy |
264
+225
| +577% | +$3.91K | ﹤0.01% | 2695 |
|
|
2019
Q1 | $65K | Buy |
39
+38
| +3,800% | +$547 | ﹤0.01% | 4783 |
|
|
2018
Q4 | $1K | Sell |
1
-59
| -98% | -$1.19K | ﹤0.01% | 6818 |
|
|
2018
Q3 | $239K | Sell |
60
-147
| -71% | -$4.18K | ﹤0.01% | 3450 |
|
|
2018
Q2 | $586K | Buy |
207
+43
| +26% | +$953 | ﹤0.01% | 2301 |
|
|
2018
Q1 | $9K | Buy |
164
+127
| +343% | +$3.02K | ﹤0.01% | 4169 |
|
|
2017
Q4 | $28K | Buy |
+37
| New | +$997 | ﹤0.01% | 3006 |
|
Simplex Trading's MRNS Position: Q1 2025 in Review
Simplex Trading sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 9,526 shares — an estimated $5K sold.
Simplex Trading first reported a position in MRNS in Q3 2017 and held it in 26 quarters. The position peaked at $1.06M in Q1 2019. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.
- Simplex Trading reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
- Simplex Trading sold 9,526 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $5K.
- Simplex Trading first reported a position in Marinus Pharmaceuticals, Inc in Q3 2017 and held it in 26 quarters.
- Simplex Trading's Marinus Pharmaceuticals, Inc position peaked at $1.06M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.
Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.